Genu Recurvatum Market
Number of pages: 100 | Report Format: PDF | Published date: June 27, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 6.49 billion |
|
Revenue Forecast in 2031 |
US$ 10.5 billion |
|
CAGR |
5.50% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, Treatment Type, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global genu recurvatum market was valued at US$ 6.49 billion in 2022 and is expected to register a revenue CAGR of 5.50% to reach US$ 10.5 billion by 2031.
Genu Recurvatum Market Fundamentals
Genu recurvatum, also known as hyperextension of the knee, is a condition characterized by excessive backward bending of the knee joint. It refers to an abnormal extension beyond the normal range of motion, resulting in the knee joint appearing hyperextended or bent backward. In a normal standing position, the knee joint should have a slight flexion, allowing it to absorb shocks and maintain stability during weight-bearing activities. However, in individuals with genu recurvatum, this natural flexion is exaggerated, causing the knee to hyperextend.
While the treatment of genu recurvatum remains focused on addressing the underlying causes and improving knee stability, several current trends and future opportunities are shaping the field. Healthcare professionals now have access to advanced motion analysis and biomechanical assessments, allowing for a better understanding of the complex interactions between joint structures, muscles, and movement patterns in individuals with genu recurvatum. This information creates personalized treatment plans and interventions addressing each patient's biomechanical deficiencies. In cases where structural abnormalities contribute to genu recurvatum, surgical interventions may be considered. Minimally invasive surgical techniques, such as arthroscopic procedures, offer the advantages of smaller incisions, reduced tissue damage, and faster recovery times. These techniques can help correct ligamentous laxity, release tight structures, or address bony deformities with less invasiveness.
Moreover, many market players are offering patients knowledge about their condition and self-management strategies. Individuals can actively participate in the treatment, optimize outcomes, and prevent further complications by receiving education on proper body mechanics, muscle-strengthening exercises, and lifestyle modifications.
Genu Recurvatum Market Dynamics
The genu recurvatum market is primarily driven by increasing incidences of genu recurvatum. Genu recurvatum can occur due to various factors, including congenital abnormalities, musculoskeletal disorders, joint injuries, and neurological conditions. Genu recurvatum, a rare orthopedic complication characterized by hyperextension of the knee, is referred to as knee hyperextension or back knee. This condition is more prevalent among women than men. It is identified in only 0.5% to 1% of individuals who require total knee arthroplasty (TKA). The rising incidence and prevalence of these underlying causes, such as ligamentous laxity, joint hypermobility, and muscle imbalances, contribute to the overall demand for genu recurvatum treatments.
Technology and product design advancements have led to the development of more effective and efficient treatment options for genu recurvatum. For instance, custom-made knee braces are designed to support and stabilize the knee joint, preventing it from hyperextending during movement. These braces have been shown to significantly reduce pain and improve function in individuals with genu recurvatum. Additionally, advancements in surgical techniques have allowed for more precise correction of the underlying anatomical issues contributing to this condition. These procedures can now be performed with greater accuracy and less invasiveness, resulting in faster recovery times and better patient outcomes.
Restraining factors in the genu recurvatum market include limited awareness among the general population about the condition and the availability of alternative treatment options. Additionally, the high cost of treatment and lack of insurance coverage for certain procedures can impede market revenue growth. Furthermore, some regions lack of skilled professionals may also impact the market's potential.
Market Ecosystem
the global genu recurvatum market is analyzed from the following perspectives: by type, treatment type, and region.
Genu Recurvatum Market by Type
Based on type, the global genu recurvatum market is segmented into internal rotary deformity recurvatum, external rotary deformity recurvatum, and non-rotary deformity recurvatum.
The internal rotary deformity recurvatum segment accounted for a significant revenue share. This is because it is a common condition that affects many people, particularly athletes and those with certain medical conditions. The segment is expected to grow in the coming years, as more people seek treatment for internal rotary deformity. Additionally, advances in technology and medical treatments are expected to drive growth in the global genu recurvatum market. Overall, the future looks bright for this market, and we can expect continued growth and innovation in the future.
Genu Recurvatum Market by Treatment Type
Based on treatment type, the global genu recurvatum market is segmented into orthoses, physical therapy, surgical treatment, and others.
The physical therapy segment accounts for most of the global genu recurvatum market revenue. This is because physical therapy is often the first line of treatment for individuals with genu recurvatum. Physical therapy can help strengthen the muscles surrounding the knee joint, improve the range of motion, and correct any imbalances contributing to genu recurvatum. Additionally, physical therapy can help prevent further damage to the knee joint and improve overall function and mobility. As a result, many individuals with genu recurvatum turn to physical therapy as a non-invasive and effective treatment option.
In the coming years, we can expect progress in research and development to enhance the treatment of genu recurvatum using orthoses. Wearable orthosis, a form of assistive device known as a robotic exoskeleton, is gaining popularity as it offers support, stability, and assistance to individuals with knee hyperextension.
Genu Recurvatum Market by Region
Based on the region, the genu recurvatum market is segmented into North America, Europe, Asia Pacific, Latin America, & the Middle East & Africa.
North America leads the global market in terms of revenue share due to the high prevalence of sports injuries in the region and the availability of advanced healthcare facilities. John Hopkins Medicine reported that in the U.S., about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year, which cause some loss of time of participation, are experienced by the participants. The United States, in particular, has a large population of athletes and sports enthusiasts at a higher risk of developing genu recurvatum. Additionally, the increasing adoption of minimally invasive surgeries and the rising demand for effective treatment options are expected to drive the growth of the genu recurvatum market in North America over the forecast period.
The Asia Pacific genu recurvatum market is projected to register 6.1% CAGR in the forecast years. This growth can be attributed to the increasing prevalence of genu recurvatum in the region, particularly in countries like China and India. Additionally, the rising geriatric population and the growing number of knee injuries and surgeries drive the demand for genu recurvatum treatment options. The availability of advanced healthcare facilities and the adoption of minimally invasive procedures are further contributing to the market growth in the Asia Pacific region.
Strategic Development Genu Recurvatum Market
Genu Recurvatum Market Competitive Landscape
The competitive landscape of the genu recurvatum market is highly fragmented, with many players operating in the market. Some of the key players in the market include Zimmer Biomet, Smith & Nephew, Stryker Corporation, DePuy Synthes, and Wright Medical Group N.V. These companies are focusing on various strategies such as product launches, collaborations, and partnerships to strengthen their market position and expand their product portfolio. In addition, the market is witnessing an increasing number of mergers and acquisitions, which is further intensifying the competition among players.
Some of the prominent companies having the largest revenue share in the global genu recurvatum market are,
Genu recurvatum, also known as hyperextension of the knee, is characterized by excessive backward bending of the knee joint.
The market growth is attributed to factors such as a significant increase in the prevalence of genu recurvatum and the introduction of many innovative products.
The global genu recurvatum market is expected to register a revenue CAGR of 5.50% in the forecast period from 2022 to 2031.
North America accounted for the majority of the global genu recurvatum market. This is due to the presence of a large patient pool and the presence of many top market players.
The global genu recurvatum market was valued at US$ 6.49 Billion in 2022.
*Insights on financial performance are subject to the availability of information in the public domain